ARTES Biotechnology GmbH

PN Update: ARTES presenting at BIO-Europe Stockholm #ARTESBio #Reagents #CDMO

🔬 **Cell Line Development: Interview with Dr. Michael Piontek from ARTES Biotechnology GmbH** Curious about how new medical treatments come to life? 🌟 In our latest interview, Dr. Michael Piontek shares insights into the world of cell line development. Learn about genetic engineering, how therapeutic proteins are made, and what's next for biotechnology. 👤 Meet Dr. Piontek and hear about his career. 🔬 Discover what cell line development involves. 💉 Find out how this technology helps treat diseases. 🚀 Explore current uses and future trends in the industry. 🤖 See how AI and automation are changing the game. Don't miss this peek into the innovations shaping the future of healthcare and medicine. 👇 Read the full interview on our blog. Find the link in the comments. #Biotechnology #CellLineDevelopment #Innovation #Healthcare #GeneticEngineering #FutureOfMedicine #ARTESBiotechnology

PN Update: ARTES and Basic Pharma near rHSA protein production #ARTESBio #Reagents #CDMO

PN Update: ARTES recombinant antigens, proteins, and enzymes #ARTESBio #Reagents #CDMO

Heading to Dubai to speak at HiConf about novel food and ARTES´ contribution in this area. #ArtesBio

WHO recommends HPV vaccination from the age of 9 to 14 years to prevent cases of cervical cancer caused in women. Note: This content serves solely for informational purposes and is not intended as a replacement for doctor’s advice. Kindly consult your doctor for HPV vaccination. #cervicalcancerawareness #cervicalcancerprevention #hpvawareness #hpv

🔬🧪🔬 New business at ARTES Biotechnology: Recombinant antigens, enzymes and functional proteins for research! We are pleased to inform you that ARTES Biotechnology has now introduced an exciting new business segment: the sale of recombinant antigens, enzymes, and functional proteins designed for use in research! Our high-quality products are produced using our platform technologies Hansenula polymorpha or E.coli. Why should you choose ARTES Biotechnology? ✅ Experience and Expertise: With our extensive experience in biotechnological research and development, we take pride in providing you with high-quality products that meet your research needs. ✅ Reliability: You can rely on us. Our products are manufactured under strict control to ensure high purity and consistency. ✅ Customer Service: At ARTES Biotechnology, customer service is our top priority. Our dedicated team is always available to answer your questions and assist you in selecting the right products.   Visit our website to learn more about our new business segment and product range. We look forward to collaborating with you and supporting your research projects!   #ARTESBio #Reagents #CDMO

ARTES announce expansion of the management board We are thrilled to announce today that Volker Jenzelewski reinforces our executive board as Managing Director beginning of the year. He will manage the company in close cooperation with Dr. Michael Piontek, Managing Director and founder of ARTES Biotechnology and with Dr. Melanie Piontek, Business Development Director. Volker Jenzelewski started his career at Rhein Biotech GmbH in 1993 after graduating in biology. In positions of increasing responsibility in technical management and GMP manufacturing, Volker eventually became Director of Process Development and Head of Manufacturing at Dynavax Europe. His final responsibility was the validation of antigen production and the support of regulatory filings for HEPLISAV-B®, the lead product of Dynavax Technologies Corporation. In the years 2010 to 2013, Volker was Managing Director of EUFETS GmbH, a CDMO in the field of advanced therapy medicinal products and a BioNTech subsidiary. He advanced the operative integration of EUFETS and the expansion into mRNA manufacturing. Volker joined us in 2014 as Director of Technology, steering the company´s development and technology transfer activities and providing technical review for business decisions. With the expansion of the management board by Volker Jenzelewski, ARTES strengthens its position as a first-class solution provider and expands its future activities. #ArtesBio #CDMO We enjoy managing ARTES together! 😀

Egyptian Drug Authority has assessed Minapharm´s Teriparatide biosimilar Bonosome produced in ARTES´ Hansenula yeast. #ArtesBio #EDA #Bonosome